The ASCEND Trial
The ASCEND Trial
THE ASCEND CLINICAL TRIAL
U.S. FDA APPROVED PIVOTAL IDE TRIAL
TREATMENT OF PATIENTS WITH NON-HEALING DIABETIC FOOT ULCERS
A Prospective, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Phase III Trial
FDA IDE #: 27971; NTC 05095389
THE ASCEND CLINICAL TRIAL
U.S. FDA APPROVED PIVOTAL IDE TRIAL
TREATMENT OF PATIENTS WITH NON-HEALING DIABETIC FOOT ULCERS
A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTI-CENTER PHASE III TRIAL
FDA IDE #: 27971; NTC 05095389
THE ASCEND CLINICAL TRIAL
U.S. FDA APPROVED PIVOTAL IDE TRIAL
TREATMENT OF PATIENTS WITH NON-HEALING DIABETIC FOOT ULCERS
A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTI-CENTER PHASE III TRIAL
FDA IDE #: 27971; NTC 05095389
TRIAL DESIGN
TRIAL FLOWCHART
TRIAL DESIGN
TRIAL FLOWCHART
Twice the Healing Rate in Half the Time
Twice the Healing Rate
in Half the Time
3 Clinical Examples of DFU Treatment with ADRCs in Prior Study*
3 Clinical Examples of DFU Treatment with ADRCs*
Advanced Wound Care Market
RIPE FOR
INNOVATION
AND DISRUPTION
Advanced Wound Care Market